• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

roberta.mazzieri@unimelb.edu.au

Credentials


Position
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
ORCID

0000-0002-5172-0927

Dr Roberta Mazzieri

Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology

64 Scholarly works
3 Projects

HIGHLIGHTS

  • 2026

    Journal article

    ID #528 Immunotherapeutic Target Discovery in Paediatric Diffuse Midline Glioma: From H3K27M Neoantigens to Dark Antigens
    DOI: 10.1093/neuped/wuag026.195
  • 2025

    Journal article

    Development of a circulating tumour cell culture model from head and neck squamous cell carcinoma
    DOI: 10.1002/VIW.20250085
  • 2025

    Journal article

    CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers
    DOI: 10.1038/s41388-024-03259-y
  • 2025

    Journal article

    Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?
    DOI: 10.1186/s13046-025-03359-x
  • 2023

    Research grants (other domestic)

    Targeting Novel Classes of Tumour Antigens in BRCA-deficient Breast Cancer to Improve Immunotherapy Responses and Overcome Resistance
  • 2023

    Research grants (ARC, NHMRC, MRFF)

    Determination of "Actionable Vaccine Targets" for Breast Cancer Immunotherapy
  • 2021

    Research grants (other domestic)

    New Immunotherapeutic Options for Triple-Negative and Brain Metastatic Breast Cancer: Next-Generation Cancer Vaccines Exploiting Alternative Classes of Tumour Antigens
Roberta Mazzieri

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    Brain-Resident MAIT Cells Infiltrate GL261 Tumors, and Activated MAIT Cell Signatures Are Associated With Improved Outcomes in Glioma
    DOI: 10.1212/NXI.0000000000200546
  • 2024

    Journal article

    Intra- and inter-tumoral heterogeneity of melanoma across different metastatic sites
    DOI: 10.1158/1538-7445.TUMBODY-B001
  • 2024

    Journal article

    Targeting alternative classes of tumor antigens to improve immunotherapy for microsatellite stable, mismatch repair-proficient colorectal cancer
    DOI: 10.1158/1538-7445.AM2024-4095
  • 2024

    Journal article

    Comparative spatial analyses of the tumor immune landscape in different mouse models of glioblastoma
    DOI: 10.1158/1538-7445.AM2024-3763
  • 2024

    Journal article

    Targeting Tumor Heterogeneity with Neoantigen-Based Cancer Vaccines
    DOI: 10.1158/0008-5472.CAN-23-2042
  • 2023

    Journal article

    Skin-Grafting and Dendritic Cell “Boosted” Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic Cancer Vaccines
    DOI: 10.3390/cells12162094

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224